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CASE REPORT
A new treatment for frostbite sequelae; Botulinum toxin
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Surgery, University Hospital North Norway, Tromsø, Norway
ABSTRACT
Frostbite sequelae are a relevant occupational injury outcome for soldiers in arctic environments.
A Caucasian male soldier suffered frostbite to both hands during a military winter exercise. He
developed sensory-motor disturbances and cold hypersensitivity. Angiography and thermogra-
phy revealed impaired blood flow while Quantitative Sensory Testing indicated impaired somato-
sensory nerve function. Two years after the initial event, he received an off label treatment with
Botulinum toxin distributed around the neurovascular bundles of each finger. After treatment,
cold sensitivity was reduced while blood flow and somato-sensory nerve function improved. The
successful treatment enabled the soldier to successfully pursue his career in the army.
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Frostbite has for decades, been a relevant problem in
the military, and continue to be so. In recent years, cold
injuries have also become more prevalent within the
civilian population due to increasing interest in extreme
outdoor recreation activities. The increasing number of
homeless people after the recent financial crisis consti-
tutes another growing group of particularly vulnerable
individuals [1]. At the same time, sufficient standard
medical treatment is currently lacking [2].
Frostbite has been defined as injury to body tissues
caused by exposure to extreme cold, typically affecting
the extremities and often involving only the skin, which
initially becomes white and hard, but in severe cases
resulting in gangrene of deeper tissues and loss of the
affected parts [3]. The pathophysiological process is
caused by heat loss sufficient to cause ice crystal for-
mation in superficial or deep tissue [1]. During the last
two decades, newer therapies aimed at prevention of
extensive tissue injuries have shown promising results
in experimental studies and case reports [1,4,5]. In addi-
tion to the acute injury, frostbite is often associated
with long-term sequelae [6]. These sequelae are less
well studied and treatment is often difficult.
Depending on the type of cold injury, cold hyper-
sensitivity, sensory loss, chronic pain, hyperhidrosis,
growth plate disturbances and osteoarthritis may
develop [7]. Long-term paraesthesia with occasional
electric shock-type sensations have also been reported
[8,9]. These sequelae may have a considerable negative
impact on the quality of life.
For the military, these sequelae may compromise
future operational capability of the soldier [10]. We
present a case of a soldier who suffered from long-
term sequelae from frostbite to his hands after a mili-
tary exercise who was successfully treated with
Botulinum toxin type A (BTX-A) injections.
Case presentation
In April 2013, in Northern Norway, a 24 year-old
Caucasian healthy male soldier participated in a qualify-
ing ski march to become a combat officer in the
Norwegian Defence Forces. He was wearing full winter
protection gear including wind protectors over his
gloves. Earlier that day the weather conditions were
fine with an air temperature around −5°C and a light
southerly breeze. During the ski march, he felt warm
and took of his gloves. The weather deteriorated rapidly
in the afternoon. Air temperatures dropped to around
−15°C and a forceful wind was now blowing towards
his right side. Although he noticed a chilling of his
hands from the wind, he still felt subjectively warm.
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After approximately 90 minutes, he decided to put on
his gloves again and noticed that the skin of his hands
had turned a blue-grey colour. His fingers felt numb
with loss of finger dexterity. Having put on his gloves,
he continued marching. After 2 hours, he felt a burning
pain in his hands and noticed that the fingers were
swollen and that blisters had developed on his fingers,
especially on the right hand side. Strongly motivated to
pass the test, he did not seek medical attention and
continued the march. His fingers became more painful
and he felt loss of sensation. After the exercise, he was
diagnosed with second-degree frostbite injuries to his
hands and was treated conservatively. The blisters were
covered with paraffin gauze and a dry bulky dressing
was applied. The wound dressings were continued until
the wounds had healed. Due to cold hypersensitivity
and pain when exposed to even a mild cold challenge,
he was assigned to indoor duties.
In 2014, he wanted to qualify for a higher rank in a
combat group. The training for this takes place in
Northern Norway with more than 6 months of winter
during which temperatures may reach −40°C. In the
autumn of 2014 he reported that his fingers still
became rapidly cold, pale and totally numb as soon
they were exposed to cold, even at a temperature of
+5°C. He felt a constant pain and loss of sensation in his
fingers resulting in reduced finger dexterity. He was
deemed unfit for outdoor military service and had to
leave the combat unit.
In May 2015, he was referred to the outpatient clinic
for Plastic Surgery at the University Hospital North
Norway. He was diagnosed with sequelae from frost-
bite. To exclude other pathological conditions further
investigations were carried out. Angiography of the
upper extremities showed open arteries on the lower
arms, but all digital arteries were described as very thin
with no dilatation after heat stimulation or hand/finger
movements. No other pathology was found.
Dynamic Infrared Thermography (DIRT) [11] was
performed to test the patient’s response to a cold
challenge. This involved measuring the skin tempera-
ture of the dorsal aspect of both hands before, imme-
diately after and for 3 minutes following a mild cold
challenge (1 min. immersion of the hand in water at
20°C). During the immersion, each hand was covered
by a thin plastic bag to avoid it becoming wet. The
skin temperatures were measured with a high defini-
tion infrared camera. The patient was wearing out-
door winter clothing to stimulate peripheral
vasodilation. Prior to the cold challenge, the patient
reported that he felt warm. Additional obtained facial
thermographic images showed the nose was vaso-
dilated, presumably due to open arterio-venous
anastomoses. DIRT showed a rapid onset of cooling
and slow rewarming of the fingers after the cold
challenge, similar to the slow warming subjects
reported by Brandstrom [12]. However, in our patient
we performed a mild cold challenge, resulting in a
clear difference between the right and left hand, the
right hand being cooler.
Quantitative Sensory Testing (QST) [13] indicated a
loss of function with regard to non-painful stimuli in the
mechanical and thermal domain (cold-, mechanical-,
and vibration detection threshold). These findings cor-
responded well with the patients’ symptoms, namely
loss of sensation in his fingers and reduced finger
dexterity.
The soldier was interested in receiving treatment. He
was informed on the off label use of BTX-A to treat
vasospastic disorders and nociceptive/neuropathic
pain disorders. He consented to a treatment with BTX-
A. Each 100 unit vial of BTX-A (Allergan, Inc. Irvine, CA)
was prepared in a standard manner with a concentra-
tion of 40 units/ml. The injections were administered at
the neurovascular bundles in the palm of each hand at
the level of the metacarpophalangeal joints (60 Units
BTX-A per hand). This resulted in a dose of 12 units of
BTX-A just at or proximal to the annular pulley A1 of the
flexor tendon sheath of each finger.
At 3 weeks follow up the patient reported that he
had less pain, warmer hands and improved sensory
function, based on his own subjective evaluation. In
November 2015, during the winter period, the patient
reported improved cold tolerance and was able to per-
form normal outdoor activities. Angiography, DIRT and
QST were repeated and the results were compared to
the pre-treatment results.
Angiography showed that the digital arteries were
more dilated and more clearly visible (Figure 1). DIRT
showed rapid and improved rewarming of all fingers
compared to the pre-treatment examination although
the rewarming of the right hand was still a bit slower
compared to the left hand at all time points during the
examinations (Figure 2). QST showed a normalisation of
sensory function apart from a marginal reduction of the
ability to detect vibration (Figure 3). Based on the
encouraging results it was agreed to repeat the treat-
ment. The same procedure with the same dose of BTX-
A of 60 U (40U/per ml) per hand was used as during the
first treatment.
At 6 weeks follow-up in January 2016, the patient
reported even further improvement. The only side
effect of both BTX-A treatments was a temporary weak-
ness of the intrinsic muscles of each hand, the lumbrical
and interosseous muscles to the 2–5 finger and the
flexor pollicis breves, the opponents and adductor
2 A. J. NORHEIM ET AL.
Figure 1. Angiography before and after treatment. Angiographic images showing the status of peripheral vessels in fingers. The
pre-treatment picture show open arteries in the right forearm. The digital arteries in the hand are displayed extraordinary gracile.
The blood-flow in the arteries are reduced, even if the fingers are stimulated with mild heat or undergoing exercise. The post-
treatment images still show reduced peripheral vascularisation, however, the digital arteries are more vasodilated and less gracile
compared with the pre-treatment display.
Figure 2. Thermography before and after treatment. Thermographic images of the hands taken on 3 different occasions. (A) the initial
examination 05.02.2015; (B) follow up examination immediately prior to BTX-A treatment 19.05.2015 and (C) follow up examination after
BTX-A treatment 17.11.2015. On the first and the third occasion, the patient’s hands was subjected to a mild cold provocation test (2-
minute period of convective cooling using a desk top fan). The images were taken after the patient had had sat in the laboratory wearing
warm clothes to ensure he was very mildly hyperthermic at the time of the examination. This was confirmed from the patient’s reported
subjective feeling as well as from thermal facial images showing that the nose (open arterio-venous anastomoses) was vasodilated. The
hand images were taken immediately after the patient arrived at the laboratory (on arrival), after the patient had been warmed up (prior
cooling) and 3 minutes after the end of the cold provocation period (3 min recovery).
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muscles of the thumb. This transitional weakness lasted
about 3 weeks.
Discussion
Frostbite can cause significant sequelae. A long-term
study on 30 patients with significant frostbite sequelae
revealed that 53% had cold hypersensitivity, 40% suf-
fered from numbness and 33% had reduced sensitivity
to touch [8,14,15]. Chronic pain is perhaps the most
frequent complaint. These sequelae can cause consider-
able discomfort and functional limitations that may last
for several years but can also have lifelong implications
for the quality of life and professional career. The latter
is of particular relevance for military personnel, since
frostbite sequelae constitutes an occupational injury
with a major career impact. Moreover, the increasing
relevance among civilians is a matter of concern, in
particular with regard to increasing interest in extreme
winter sports activities [1,2] as well as in those with
limited possibilities to protect themselves, such as
homeless people.
The pathophysiology of cold injuries and sequelae
remains still poorly understood although peripheral
neurovascular damage plays an important role [6]. The
treatment of these sequelae is difficult. Cold
hypersensitivity and pain are clearly a threat to the
functionality, such as in the present case of this soldier.
Recently, BTX-A has been successfully used in the
treatment of Raynaud’s phenomenon, well known as
an exaggerated digital vasospasm, most commonly
due to stimuli like cold and emotional stress [15]. In
these patients BTX-A improved pain control, decreased
numbness and increased blood perfusion to the fingers.
BTX-A blocks the release of the neurotransmitter acet-
ylcholine at the motor end plate terminals and as a
result, smooth muscle vasoconstriction is inhibited
[16]. BTX-A has also two other effects. It blocks the
transmission of norepinephrine and prevents sympa-
thetic vasoconstriction of vascular smooth muscle [17].
In addition BTX-A blocks recruitment of specific α2-
adrenoreceptors, which decreases the activity of chroni-
cally upregulated C-fiber nociceptors. This causes sub-
sequent reduction in cold-induced vascular smooth
muscle constriction and pain [18]. The above current
knowledge lends weight to the idea of using BTX-A to
treat frostbite sequelae.
Our study using angiography, DIRT and QST indicate
that BTX-A has positive effects on skin perfusion, cold
hypersensitivity and pain in a patient with frostbite
sequelae. Further studies are warranted to investigate
the long-term effects of BTX-A in these patients.
Figure 3. Quantitative Sensory Testing (QST) before and after treatment. The z-transformed pattern of 11 QST subtests (shown
without dynamic mechanical allodynia (DMA) and paradoxical heat sensation (PHS), which were normal). QST reveals thermal
hypoesthesia of cold stimuli (CDT) in the directly affected area (middle finger), most likely related to the loss of small fiber function
(Aδ fibres). The ability to detect minimal mechanical stimuli (MDT) is reduced within (long finger), as well as outside (thenar of the
same hand) the affected area, as is the ability to detect vibration (VDT) in the hand area. These mechanical deficits reflect most
likely a loss of function of large diameter fibers (Aβ fibres). With the exception of VDT, treatment with BTX-A normalised the QST
pattern. The red circles in the figure indicate values measured outside the two Standard Deviation (SD).
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Although this patient had received his injury some
years prior to treatment, we speculate that early treat-
ment of frostbite sequelae with BTX-A may be advanta-
geous. Early treatment may reduce the symptoms
associated with frostbite sequelae and thereby reduce
the period in which the patient is unable to perform his
or her normal duties as a soldier in a cold environment.
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